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Introduction 
Data on respondent use of prescription and select over-the-counter (aspirin-containing and non-
steroidal anti-inflammatory) medications were collected during the Wave IV in-home interview.  
The process of collecting the prescription medication data, therapeutically classifying the 
prescription medications, and structuring a file of the therapeutic classifications for 
dissemination to users is described below.  The questions concerning use of aspirin-containing 
and non-steroidal anti-inflammatory medications are detailed in the Section 6 codebook of the 
in-home interview.  
 
Collection of Prescription Medication Data 
 
Initial Contact  
 
At the end of the phone conversation confirming the interview appointment date and time, the 
field interviewer told the respondent that information on use of medications would be collected 
at the interview.  The interviewer also suggested that it would help to have their medications 
handy at that time so they could be recorded properly.  Doing so alerted the respondent to bring 
medication containers to the interview.   
 
Interview 
 
Medication data were collected at the end of the Biomarker section of the interview using a 
computer-assisted questionnaire.  The questions followed a preface read by the interviewer to 
the respondent: 
 
“As you know, I want to record all prescription medications that you have used in the 
past four weeks. These medications include solid and non-solid formulations that you 
may swallow, inhale, apply to the skin or hair, inject, implant, or place in the ears, eyes, 
nose, mouth, or any other part of the body. (If female add: This also includes prescription 
birth control.)”   
 
This preface was followed by Question 1: 
 
“Have you taken any prescription medications in the last four weeks?” 
 
Of the 15,701 Wave IV respondents, 9,876 (63%) answered “No”, 5,820 (37%) “Yes”, 4 (<1%) 
“Don’t know”, and 1 (<1%) refused to answer the question.  If the respondent answered “Yes”, 
the interviewer was presented with the following instruction: 
 
“If the interview is being conducted in the respondent’s home or the medications are 
conveniently available (e.g., in a purse) ask the respondent to assemble the medications 
or their containers now so that you can record information about them.  If the respondent 
is unable or unwilling to assemble them now, ask him/her to list them from memory.”  
 
The interviewer then recorded whether the respondent presented each medication or its 
container at the interview or listed the medication name from memory.  Of the 10,711 
medications reported by the 5,820 respondents who answered “Yes” to Question 1, 2,345 (22%) 
were from memory. 
  
Next, the interviewer typed the name of each medication, one by one, into the computer.  As the 
interviewer began typing each medication name, a look-up list of medications with identical or 
  
similar names was displayed on screen.  The interviewer highlighted and selected the name on 
the look-up list matching each medication. In the absence of a matching name on the look-up 
list, the interviewer typed “Name not on list”. 
 
During the Wave IV Pretest, the look-up list of medications available to the interviewer was 
based on an August 1, 2006 copy of a medication information and classification database 
(Multum LexiconTM, Cerner Multum, Inc.; Denver, CO).  This look-up list was created by 
excerpting all 15,871 generic and brand names that were included in the database at that time.  
New medication names were added to the look-up list on December 17, 2007, bringing the total 
to 18,110 medication names during the Wave IV Main Study.  
 
When the medication name typed by the interviewer was not on the look-up list, the interviewer 
manually keyed the entire medication name.  Of the 10,711 medications reported by 
respondents, 117 (1%) were manually keyed by the interviewer.  The medication name was 
recalled from memory for 50 (43%) of these 117 medications. 
 
After the first medication was entered, the interviewer asked Question 2: 
 
“Do you take any additional medications?”   
 
To this question, 2,533 (43.5%) respondents replied, “Yes”.  For those responding “Yes”, the 
second medication was entered into the computer as described above and Question 2 was 
repeated until the respondent reported taking no other medications.  Wave IV respondents who 
reported taking medication took an average of 1.8 (range: 1-18) medications.  
 
 
Therapeutic Classification of Prescription Medications 
 
In 2009, a contract allowing for therapeutic classification of the prescription medications in the 
look-up list using an updated version of the Multum LexiconTM (Lexicon PlusTM, Lexi-Comp®, 
Inc.; Hudson, OH) was executed.  Of the 10,711 medications reported by respondents, 153 
(1%) could not be automatically assigned to a therapeutic class using this database.  A general 
internist and cardiovascular epidemiologist with expertise in medication classification manually 
assigned therapeutic classes to the 153 medications using two on-line coding databases (Lexi-
Comp® On-LineTM, Lexi-Comp®, Inc.; Hudson, OH and MICROMEDEX® 1.0, Thomson Reuters 
Healthcare, Inc; Philadelphia, PA).  The Wave IV medication file therefore contains the 
therapeutic class for 10,711 medications.   
  
In the data file, the nine-digit therapeutic classification codes associated with each medication 
include a hierarchical series of up to three, three-digit codes representing, from left to right, the 
(general) therapeutic class, the (more specific) therapeutic subclass, and (most specific) 
therapeutic subgroup.  For example, a medication coded 001-009-161 is in the anti-infective 
class, cephalosporins subclass, and third generation cephalosporins subgroup.  A medication 
coded 001-018-*** is in the anti-infective class and aminoglycosides subclass.  In other words, 
three, right-sided asterisks (***) in the nine-digit code indicate that subgrouping was impossible 
and six (***-***) indicate that both subclassification and subgrouping were impossible.  A 
medication coded 998-998-998 indicates that the respondent could not (or refused to) name the 
medication he / she reported taking, or that classification of it was impossible. 
 
Because the study did not collect indications for treatment and some medications are used on- 
or off-label to treat a variety of conditions, each medication may be associated with up to four 
unique, nine-digit therapeutic classification codes, i.e. Sets 1-4.  See Therapeutic Classification 
Codes below to link the three-digit codes and the corresponding class, subclass, and subgroup 
names. 
  
 
Structure of the Prescription Medication Data File 
 
The disseminated prescription medication data file is hierarchical, i.e. it is a medication-level file 
with the therapeutic classification for each medication listed as one observation.  If a respondent 
reported taking more than one medication, the respondent AID will be in the file more than once.  
The file includes the following variables: 
 
AID  Respondent identifier 
SET1 Therapeutic Classification – Set 1 
SET2 Therapeutic Classification – Set 2 
SET3 Therapeutic Classification – Set 3 
SET4 Therapeutic Classification – Set 4 
MED_TOT Total number of medications reported by the respondent 
 
 
Given all of the former complexities, Add Health users possessing no to little prior 
experience working with medication data are strongly advised to collaborate with a 
health care professional familiar with the challenges and pitfalls associated with doing 
so.   
  
 Copyright 2009 Lexi-comp, Inc. and Cerner Multum, Inc.  All rights reserved. 
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Table.  Therapeutic Classification Codes 
Code Name 
001 anti-infectives 
002 amebicides 
003 anthelmintics 
004 antifungals 
005 antimalarial agents 
006 antituberculosis agents 
007 antiviral agents 
008 carbapenems 
009 cephalosporins 
010 leprostatics 
011 macrolide derivatives 
012 miscellaneous antibiotics 
013 penicillins 
014 quinolones 
015 sulfonamides 
016 tetracyclines 
017 urinary anti-infectives 
018 aminoglycosides 
019 antihyperlipidemic agents 
020 antineoplastics 
021 alkylating agents 
022 antibiotics/antineoplastics 
023 antimetabolites 
024 hormones/antineoplastics 
025 miscellaneous antineoplastics 
026 mitotic inhibitors 
027 radiopharmaceuticals 
028 biologicals 
030 antitoxins and antivenins 
031 bacterial vaccines 
032 colony stimulating factors 
033 immune globulins 
034 in vivo diagnostic biologicals 
036 recombinant human erythropoietins 
037 toxoids 
038 viral vaccines 
039 miscellaneous biologicals 
040 cardiovascular agents 
041 agents for hypertensive emergencies 
042 angiotensin converting enzyme inhibitors 
043 antiadrenergic agents, peripherally acting 
044 antiadrenergic agents, centrally acting 
045 antianginal agents 
046 antiarrhythmic agents 
047 beta-adrenergic blocking agents 
048 calcium channel blocking agents 
049 diuretics 
050 inotropic agents 
051 miscellaneous cardiovascular agents 
052 peripheral vasodilators 
  
053 vasodilators 
054 vasopressors 
055 antihypertensive combinations 
056 angiotensin II inhibitors 
057 central nervous system agents 
058 analgesics 
059 miscellaneous analgesics 
060 narcotic analgesics 
061 nonsteroidal anti-inflammatory agents 
062 salicylates 
063 analgesic combinations 
064 anticonvulsants 
065 antiemetic/antivertigo agents 
066 antiparkinson agents 
067 anxiolytics, sedatives, and hypnotics 
068 barbiturates 
069 benzodiazepines 
070 miscellaneous anxiolytics, sedatives and hypnotics 
071 CNS stimulants 
072 general anesthetics 
073 muscle relaxants 
074 neuromuscular blocking agents 
076 miscellaneous antidepressants 
077 miscellaneous antipsychotic agents 
079 psychotherapeutic combinations 
080 miscellaneous central nervous system agents 
081 coagulation modifiers 
082 anticoagulants 
083 antiplatelet agents 
084 heparin antagonists 
085 miscellaneous coagulation modifiers 
086 thrombolytics 
087 gastrointestinal agents 
088 antacids 
089 anticholinergics/antispasmodics 
090 antidiarrheals 
091 digestive enzymes 
092 gallstone solubilizing agents 
093 GI stimulants 
094 H2 antagonists 
095 laxatives 
096 miscellaneous GI agents 
097 hormones 
098 adrenal cortical steroids 
099 antidiabetic agents 
100 miscellaneous hormones 
101 sex hormones 
102 contraceptives 
103 thyroid drugs 
104 immunosuppressive agents 
105 miscellaneous agents 
106 antidotes 
107 chelating agents 
108 cholinergic muscle stimulants 
109 local injectable anesthetics 
110 miscellaneous uncategorized agents 
111 psoralens 
  
112 radiocontrast agents 
113 genitourinary tract agents 
114 illicit (street) drugs 
115 nutritional products 
116 iron products 
117 minerals and electrolytes 
118 oral nutritional supplements 
119 vitamins 
120 vitamin and mineral combinations 
121 intravenous nutritional products 
122 respiratory agents 
123 antihistamines 
124 antitussives 
125 bronchodilators 
126 methylxanthines 
127 decongestants 
128 expectorants 
129 miscellaneous respiratory agents 
130 respiratory inhalant products 
131 antiasthmatic combinations 
132 upper respiratory combinations 
133 topical agents 
134 anorectal preparations 
135 antiseptic and germicides 
136 dermatological agents 
137 topical anti-infectives 
138 topical steroids 
139 topical anesthetics 
140 miscellaneous topical agents 
141 topical steroids with anti-infectives 
143 topical acne agents 
144 topical antipsoriatics 
146 mouth and throat products 
147 ophthalmic preparations 
148 otic preparations 
149 spermicides 
150 sterile irrigating solutions 
151 vaginal preparations 
153 plasma expanders 
154 loop diuretics 
155 potassium-sparing diuretics 
156 thiazide diuretics 
157 carbonic anhydrase inhibitors 
158 miscellaneous diuretics 
159 first generation cephalosporins 
160 second generation cephalosporins 
161 third generation cephalosporins 
162 fourth generation cephalosporins 
163 ophthalmic anti-infectives 
164 ophthalmic glaucoma agents 
165 ophthalmic steroids 
166 ophthalmic steroids with anti-infectives 
167 ophthalmic anti-inflammatory agents 
168 ophthalmic lubricants and irrigations 
169 miscellaneous ophthalmic agents 
170 otic anti-infectives 
171 otic steroids with anti-infectives 
  
172 miscellaneous otic agents 
173 HMG-CoA reductase inhibitors 
174 miscellaneous antihyperlipidemic agents 
175 protease inhibitors 
176 NRTIs 
177 miscellaneous antivirals 
178 skeletal muscle relaxants 
179 skeletal muscle relaxant combinations 
180 adrenergic bronchodilators 
181 bronchodilator combinations 
182 androgens and anabolic steroids 
183 estrogens 
184 gonadotropins 
185 progestins 
186 sex hormone combinations 
187 miscellaneous sex hormones 
191 narcotic analgesic combinations 
192 antirheumatics 
193 antimigraine agents 
194 antigout agents 
195 5HT3 receptor antagonists 
196 phenothiazine antiemetics 
197 anticholinergic antiemetics 
198 miscellaneous antiemetics 
199 hydantoin anticonvulsants 
200 succinimide anticonvulsants 
201 barbiturate anticonvulsants 
202 oxazolidinedione anticonvulsants 
203 benzodiazepine anticonvulsants 
204 miscellaneous anticonvulsants 
205 anticholinergic antiparkinson agents 
206 miscellaneous antiparkinson agents 
208 SSRI antidepressants 
209 tricyclic antidepressants 
210 phenothiazine antipsychotics 
211 platelet aggregation inhibitors 
212 glycoprotein platelet inhibitors 
213 sulfonylureas 
214 non-sulfonylureas 
215 insulin 
216 alpha-glucosidase inhibitors 
217 bisphosphonates 
218 alternative medicines 
219 nutraceutical products 
220 herbal products 
222 penicillinase resistant penicillins 
223 antipseudomonal penicillins 
224 aminopenicillins 
225 beta-lactamase inhibitors 
226 natural penicillins 
227 NNRTIs 
228 adamantane antivirals 
229 purine nucleosides 
230 aminosalicylates 
231 nicotinic acid derivatives 
232 rifamycin derivatives 
233 streptomyces derivatives 
  
234 miscellaneous antituberculosis agents 
235 polyenes 
236 azole antifungals 
237 miscellaneous antifungals 
238 antimalarial quinolines 
239 miscellaneous antimalarials 
240 lincomycin derivatives 
241 fibric acid derivatives 
242 psychotherapeutic agents 
243 leukotriene modifiers 
244 nasal lubricants and irrigations 
245 nasal steroids 
246 nasal antihistamines and decongestants 
247 nasal preparations 
248 topical emollients 
249 antidepressants 
250 monoamine oxidase inhibitors 
251 antipsychotics 
252 bile acid sequestrants 
253 anorexiants 
254 immunologic agents 
256 interferons 
257 immunosuppressive monoclonal antibodies 
261 heparins 
262 coumarins and indandiones 
263 impotence agents 
264 urinary antispasmodics 
265 urinary pH modifiers 
266 miscellaneous genitourinary tract agents 
267 ophthalmic antihistamines and decongestants 
268 vaginal anti-infectives 
269 miscellaneous vaginal agents 
270 antipsoriatics 
271 thiazolidinediones 
272 proton pump inhibitors 
273 lung surfactants 
274 cardioselective beta blockers 
275 non-cardioselective beta blockers 
276 dopaminergic antiparkinsonism agents 
277 5-aminosalicylates 
278 cox-2 inhibitors 
279 gonadotropin releasing hormones 
280 thioxanthenes 
281 neuraminidase inhibitors 
282 meglitinides 
283 thrombin inhibitors 
284 viscosupplementation agents 
285 factor Xa inhibitors 
286 mydriatics 
287 ophthalmic anesthetics 
288 5-alpha-reductase inhibitors 
289 antihyperuricemic agents 
290 topical antibiotics 
291 topical antivirals 
292 topical antifungals 
293 glucose elevating agents 
295 growth hormones 
  
296 inhaled corticosteroids 
297 mucolytics 
298 mast cell stabilizers 
299 anticholinergic bronchodilators 
300 corticotropin 
301 glucocorticoids 
302 mineralocorticoids 
303 agents for pulmonary hypertension 
304 macrolides 
305 ketolides 
306 phenylpiperazine antidepressants 
307 tetracyclic antidepressants 
308 SSNRI antidepressants 
309 miscellaneous antidiabetic agents 
310 echinocandins 
311 dibenzazepine anticonvulsants 
312 cholinergic agonists 
313 cholinesterase inhibitors 
314 antidiabetic combinations 
315 glycylcyclines 
316 cholesterol absorption inhibitors 
317 antihyperlipidemic combinations 
318 insulin-like growth factor 
319 vasopressin antagonists 
320 smoking cessation agents 
321 ophthalmic diagnostic agents 
322 ophthalmic surgical agents 
323 antineoplastic monoclonal antibodies 
324 antineoplastic interferons 
325 sclerosing agents 
327 antiviral combinations 
328 antimalarial combinations 
329 antituberculosis combinations 
330 antiviral interferons 
331 radiologic agents 
332 radiologic adjuncts 
333 miscellaneous iodinated contrast media 
334 lymphatic staining agents 
335 magnetic resonance imaging contrast media 
336 non-iodinated contrast media 
337 ultrasound contrast media 
338 diagnostic radiopharmaceuticals 
339 therapeutic radiopharmaceuticals 
340 aldosterone receptor antagonists 
341 atypical antipsychotics 
342 renin inhibitors 
343 tyrosine kinase inhibitors 
344 nasal anti-infectives 
345 fatty acid derivative anticonvulsants 
346 gamma-aminobutyric acid reuptake inhibitors 
347 gamma-aminobutyric acid analogs 
348 triazine anticonvulsants 
349 carbamate anticonvulsants 
350 pyrrolidine anticonvulsants 
351 carbonic anhydrase inhibitor anticonvulsants 
352 urea anticonvulsants 
353 anti-angiogenic ophthalmic agents 
  
354 H. pylori eradication agents 
355 functional bowel disorder agents 
356 serotoninergic neuroenteric modulators 
357 growth hormone receptor blockers 
358 metabolic agents 
359 peripherally acting antiobesity agents 
360 lysosomal enzymes 
361 miscellaneous metabolic agents 
362 chloride channel activators 
363 probiotics 
364 antiviral chemokine receptor antagonist 
365 medical gas 
366 integrase strand transfer inhibitor 
368 non-ionic iodinated contrast media 
369 ionic iodinated contrast media 
370 otic steroids 
371 dipeptidyl peptidase 4 inhibitors 
372 amylin analogs 
373 incretin mimetics 
374 cardiac stressing agents 
375 peripheral opioid receptor antagonists 
376 radiologic conjugating agents 
377 prolactin inhibitors 
378 drugs used in alcohol dependence 
379 next generation cephalosporins 
380 topical debriding agents 
381 topical depigmenting agents 
382 topical antihistamines 
383 antineoplastic detoxifying agents 
384 platelet-stimulating agents 
385 group I antiarrhythmics 
386 group II antiarrhythmics 
387 group III antiarrhythmics 
388 group IV antiarrhythmics 
389 group V antiarrhythmics 
390 hematopoietic stem cell mobilizer 
391 mTOR kinase inhibitors 
392 otic anesthetics 
393 cerumenolytics 
394 topical astringents 
 
 
